Xponance Inc. lifted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 2.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 57,471 shares of the pharmaceutical company’s stock after acquiring an additional 1,331 shares during the period. Xponance […]
Neo Ivy Capital Management purchased a new position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) during the fourth quarter, HoldingsChannel.com reports. The fund purchased 1,866 shares of the pharmaceutical company’s stock, valued at approximately $539,000. A number of other institutional investors and hedge funds have also recently modified their holdings of VRTX. Sequoia Financial […]
Neuberger Berman Group LLC raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) by 13.3% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 301,101 shares of the pharmaceutical company’s stock after acquiring an additional 35,292 shares during the […]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) CAO Kristen Ambrose sold 289 shares of the company’s stock in a transaction on Tuesday, May 30th. The shares were sold at an average price of $329.82, for a total value of $95,317.98. Following the completion of the sale, the chief accounting officer now owns 6,838 shares of […]
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Rating) CAO Kristen Ambrose sold 289 shares of the business’s stock in a transaction on Tuesday, May 30th. The stock was sold at an average price of $329.82, for a total transaction of $95,317.98. Following the transaction, the chief accounting officer now directly owns 6,838 shares of the company’s […]